While the fate of the lien-activation fees imposed by Senate Bill 863 remains in limbo, a Los Angeles-based manufacturer of medical foods has entered into an agreement that allows its customer physicians to sell their workers' compensation claims receivables.Targeted Medical Pharma Inc. disclosed the agreement in a Form 8-K filing with the U.S. Securities and Exchange Commission. The deal involves TMP, its physician customers and Cambridge Medical Funding Group, a Delaware LLC that purchases the receivables owed to the physicians by insurance carriers.The insurers’ obligations stem f...
Comments